GLP-1 and Surgery: When to Stop Semaglutide Before an Operation

You have an upcoming surgical procedure. You have been reading about anesthesia prep, fasting requirements, and what to expect. Then you noticed a question in the pre-surgical paperwork asking about medications, and you realized your GLP-1 injection might affect the procedure or anesthesia. Now you’re wondering if you need to stop it, when to stop it, and who to tell.

This is a critical coordination point between your GLP-1 provider and your surgical team. Here is what you need to know and what to ask.

Why GLP-1 Medications Affect Anesthesia Safety

GLP-1 medications work by slowing your gastric emptying rate. In other words, they slow the rate at which food and liquid move from your stomach into your small intestine. This is how they reduce appetite and create a longer sense of fullness after eating.

The problem comes during general anesthesia. Even when you follow standard pre-surgical fasting instructions (nothing by mouth for 8 hours or more before the procedure), a GLP-1-treated stomach may still contain undigested food or fluid. When you are under general anesthesia, your protective airway reflexes are suppressed. This creates a risk of aspiration: inhaling stomach contents into your lungs. Aspirated gastric material can cause chemical pneumonitis, a serious lung injury that requires hospitalization and can be life-threatening.

In a 2024 study that used gastric ultrasound right before elective procedures, 56% of people taking a weekly GLP-1 medication had increased stomach contents despite following fasting guidelines, compared with 19% of people not taking one.^[2] This is not a theoretical risk. It shows up on imaging.

The ASA Guidance on GLP-1 and Anesthesia

In 2023, the American Society of Anesthesiologists (ASA) issued consensus-based guidance^[1] on managing GLP-1 medications before procedures requiring anesthesia or sedation. For elective procedures, it suggested:

• Weekly GLP-1 medications (such as weekly semaglutide injections): consider holding the dose for one week before the procedure
• Daily GLP-1 medications (daily injections or oral semaglutide): consider holding the dose on the day of the procedure

In October 2024, the ASA and four other societies (the American Gastroenterological Association, the American Society for Metabolic and Bariatric Surgery, the International Society of Perioperative Care of Patients with Obesity, and the Society of American Gastrointestinal and Endoscopic Surgeons) published updated multi-society guidance.^[3] The main points:

• Most people can keep taking their GLP-1 medication before elective surgery.
• People at higher risk of delayed stomach emptying may be asked to follow a liquid-only diet for 24 hours before the procedure. Higher risk includes people in the dose-escalation phase (when doses are being increased, typically 4 to 8 weeks), people on higher doses, and people with nausea, vomiting, abdominal pain, or constipation.
• Elective surgery may be postponed until the escalation phase has passed or GI symptoms have settled.
• The anesthesia team may adjust the anesthesia plan or use point-of-care ultrasound to check the stomach right before the procedure.
• Stopping has trade-offs. The team weighs the aspiration risk against the risks of holding the medication, such as higher blood sugar in people with diabetes.

These are professional society guidance documents, not fixed rules. Your surgeon and anesthesiologist decide what applies based on your specific procedure, your health status, the type of anesthesia planned, and other clinical factors, ideally together with the provider who prescribes your GLP-1. Some surgical centers still ask people to hold a dose, so follow the instructions your team gives you.

What You Need to Do: A Clear Timeline

You have several key steps to take before your procedure. The timing depends on when you are scheduled.

Step 1: Inform Your Surgical Team (Before Scheduling or at First Consultation)

When you schedule your surgery or at your pre-surgical consultation, directly tell both your surgeon and your anesthesiologist that you are taking a GLP-1 medication. Do not rely on them to discover this in your medical record. Say it out loud during your consultation. Write it down on the pre-surgical paperwork under medications.

Specify which GLP-1 medication, dose, and formulation you are taking. For example: “I am taking semaglutide 1 mg weekly” or “I take oral semaglutide daily.” Mention whether you recently started or increased your dose, and whether you have nausea, vomiting, or constipation. These details matter because the plan depends on whether the medication is weekly or daily and on your risk of delayed stomach emptying.

Step 2: Notify Your GLP-1 Provider

Contact the provider who prescribed your GLP-1 medication and tell them about your upcoming procedure. This provider is usually not your surgeon; it is the licensed provider (at a telehealth program, primary care practice, or specialist office) who manages your prescription. They need to know the date of your surgery so they can weigh in on whether a hold or dose change makes sense and help coordinate with your surgical team if needed.

Your GLP-1 provider can also answer questions about special considerations for your health status or any other medications you take. If you take a GLP-1 for type 2 diabetes, ask how to manage your blood sugar if a dose is held.

Step 3: Confirm the Hold Window With Your Surgical Team

Once your surgical team reviews your medication list, ask them explicitly whether you should keep taking your GLP-1, hold a dose, or follow a liquid diet before the procedure, and for how long. Get this in writing (or in an email or message from the surgical office) if possible.

Do not assume that the surgical office will reach out to you or to your GLP-1 provider. You are the bridge between these two care teams. Take ownership of the coordination.

Step 4: Hold Your Medication as Directed

If your surgical team asks you to hold your GLP-1 medication, stop on the date they specify. Under the 2023 ASA approach, that meant skipping the weekly dose due in the week before surgery, or skipping a daily dose (injection or oral semaglutide) on the day of surgery. If your team asks for a 24-hour liquid diet instead, follow their instructions on what counts as liquid and when to stop. If they tell you to keep taking your medication, keep your normal schedule.

Mark the date on your calendar so you do not accidentally take a dose during the hold window.

Step 5: Plan Your Restart

If you held your medication, ask when to restart before you leave the hospital or surgery center. Restart is usually discussed once you are eating and drinking normally and your GI function has returned to baseline. There is no single standard window: it depends on your procedure (bariatric and other GI surgery usually take longer), your recovery, and how long you were off the medication. Your surgical team and your GLP-1 provider will give you specific guidance.

See the linked resource below on resuming GLP-1 after surgery for detailed guidance on restart and re-titration.

Timeline: What Happens When

Below is a visual summary of the key dates and actions:

Schedule Surgery

Contact your surgical team and schedule the procedure. At this appointment or during a pre-op consultation, tell your surgeon and anesthesiologist that you are on a GLP-1 medication.

Pre-Surgery Consultations (1 to 4 Weeks Before)

Meet with your surgical team. Ask them whether you should continue, hold, or change anything about your GLP-1 before the procedure. Notify the provider who prescribes your GLP-1 of your surgery date. Ask whether they will document the plan in your chart or contact your surgical team directly.

Hold Window (Varies by Medication)

If your team asks you to hold your GLP-1, stop on the date they give you. Under the 2023 ASA approach, weekly medications were held for the week before surgery and daily medications on the day of surgery. Under the 2024 guidance, many people continue their medication, and some follow a 24-hour liquid diet instead.

Day of Surgery

Tell the anesthesia team again that you take a GLP-1 medication and when you took your last dose. They may check your stomach with ultrasound or adjust the anesthesia plan to lower the risk of aspiration.

Recovery (First 1 to 2 Weeks)

Follow your surgical team’s post-operative diet. Start with clear liquids, progress to soft foods as tolerated. Your GI system is healing.

Restart Window (When Your Team Clears You)

Once normal oral intake is established and your provider clears you, restart your GLP-1 medication as directed. After a longer gap, your prescriber may restart you at a lower dose and step up gradually.

Special Situations: Urgent or Emergency Surgery

The timeline above assumes you have time to plan. If you need urgent or emergency surgery, the situation is different. Tell the surgical and anesthesia team immediately that you are on a GLP-1 medication. They will manage the aspiration risk in real time using standard techniques: modified anesthesia induction, aspiration precautions, careful airway management. The 2023 ASA guidance says urgent and emergency procedures should proceed, with the patient treated as having a full stomach.^[1] Trust your surgical team to handle the situation with appropriate clinical protocols.

Who Else Should Know You Are on GLP-1?

Your surgical team needs to know. Your anesthesiologist must know. Your GLP-1 provider must know. But the key question many people ask is: what if I am having a simple procedure under local anesthesia, not general anesthesia? Or a procedure with sedation, not full anesthesia?

The guidance focuses on general anesthesia and deep sedation, where protective airway reflexes are suppressed. If you are unsure whether your procedure falls into this category, ask your anesthesiologist. When in doubt, tell them you are on a GLP-1 medication and ask whether you need to change anything. They will advise.

Key People to Inform

Write these down so you do not forget:

• Your surgeon: tell at pre-op
• Your anesthesiologist: tell during the pre-anesthesia evaluation
• Your primary care provider (if different from above): tell so they have complete medication information
• The provider who prescribes your GLP-1: tell so they can coordinate on the plan and restart timing
• The surgical office staff (nurses, scheduler): they may not be the surgeon, but they enter medications into your pre-op chart

What Happens if You Stop Your GLP-1 Temporarily?

A short hold of a day or a week is not expected to undo your progress. Your appetite may return toward its baseline level during the hold period, and you might feel hungrier than usual for that week. This is temporary and expected. If you take a GLP-1 for type 2 diabetes, a hold can raise your blood sugar, which is one reason the 2024 guidance asks teams to weigh the risks of stopping.^[3] Ask your prescriber how to monitor it. Once you restart after surgery, the medication’s effects typically return.

For detailed guidance on managing this medication gap, see the article on missed doses in the medication management section (linked below).

Elective vs. Urgent Surgery: What Changes

If your surgery is elective (scheduled weeks or months in advance), you have time to coordinate the plan carefully with your surgical team. If they ask you to hold your medication, you can plan ahead for up to a week without its appetite-reducing effect. If you recently started or increased your dose, or have ongoing GI symptoms, they may suggest scheduling the procedure after that phase has passed.

If your surgery is urgent or emergency (scheduled within 24 to 48 hours), your surgical and anesthesia teams will manage the GLP-1-related aspiration risk using clinical protocols. Urgent procedures generally go ahead, with the team treating your stomach as full and taking appropriate precautions.

Important: Never Stop or Restart Without Guidance

Do not stop or restart your GLP-1 medication on your own without guidance from your surgical team and your GLP-1 provider. Changing the medication schedule should be a coordinated decision between the provider managing your medication and the team managing your surgery. You are the messenger between these two teams. Your job is to make sure both teams know about the medication. Their job is to give you clear guidance on the plan before surgery and on the restart.

If you stop without guidance, you may stop when you did not need to (which can affect blood sugar if you have diabetes) or follow a different plan than your anesthesia team expects. If you restart too early, before your GI function is fully normal, you may have side effects or compromise your recovery. Both decisions require medical judgment from someone who knows your individual situation.

After Surgery: Restart and Recovery

Once your procedure is complete and your body is healing, you will want to resume your GLP-1 medication if you held it. The restart is not always immediate. Timing depends on the type of surgery and how quickly you are eating normally again; after bariatric or other GI surgery it is usually longer. Your surgical team and prescriber will give you a specific timeline based on the type of surgery you had.

After a longer gap, the restart may involve a lower dose and stepping up gradually over several weeks, similar to how you started the medication initially. Your prescriber decides. See the linked guide on resuming GLP-1 after surgery for more on this process.

Summary: Your Action Items

1. Schedule surgery. Tell your surgeon and anesthesiologist you are on a GLP-1 medication at the first opportunity.
2. Write it down. List GLP-1 medication on all pre-surgical paperwork under medications.
3. Name the medication. Be specific: “semaglutide 1 mg weekly injection” or “oral semaglutide daily,” and mention any recent dose increase or GI symptoms.
4. Notify your GLP-1 provider. Tell the provider who prescribes your GLP-1 about your procedure date.
5. Confirm the plan. Ask your surgical team whether to continue, hold, or follow a liquid diet, and when.
6. Mark your calendar. Note the date you should stop (if you are holding) and the date you plan to restart.
7. Ask about restart timing. Before your surgery, ask your surgical team roughly when you can resume medication.
8. Plan your restart. After surgery, work with your GLP-1 provider on a restart schedule once your GI function is normal.

This coordination takes a few minutes of effort now and lowers the risk of complications during your procedure. Your surgical team cannot manage a risk they do not know about. Your GLP-1 provider cannot advise on timing they do not know is needed. Clear communication between you and both care teams is the foundation of safe surgical care.

Citations

[1] American Society of Anesthesiologists Task Force on Preoperative Fasting. “American Society of Anesthesiologists Consensus-Based Guidance on Preoperative Management of Patients (Adults and Children) on Glucagon-Like Peptide-1 (GLP-1) Receptor Agonists.” 2023 (page last updated November 1, 2024). https://www.asahq.org/about-asa/newsroom/news-releases/2023/06/american-society-of-anesthesiologists-consensus-based-guidance-on-preoperative (2023 suggestion to hold weekly GLP-1 medications for a week and daily doses on the day of an elective procedure; urgent procedures treated as full stomach.)

[2] Sen S, Potnuru PP, Hernandez N, et al. “Glucagon-Like Peptide-1 Receptor Agonist Use and Residual Gastric Content Before Anesthesia.” JAMA Surgery. 2024;159(6):660-667. https://pubmed.ncbi.nlm.nih.gov/38446466/ (Gastric ultrasound before elective procedures: increased residual gastric content in 56% of weekly GLP-1 users vs 19% of non-users.)

[3] Kindel TL, Wang AY, Wadhwa A, et al.; American Gastroenterological Association, American Society for Metabolic and Bariatric Surgery, American Society of Anesthesiologists, International Society of Perioperative Care of Patients with Obesity, Society of American Gastrointestinal and Endoscopic Surgeons. “Multisociety clinical practice guidance for the safe use of glucagon-like peptide-1 receptor agonists in the perioperative period.” Surgery for Obesity and Related Diseases. 2024;20(12):1183-1186. https://pubmed.ncbi.nlm.nih.gov/39482213/ ASA summary (October 29, 2024): https://www.asahq.org/about-asa/newsroom/news-releases/2024/10/new-multi-society-glp-1-guidance (Most patients continue GLP-1 medications before elective surgery; 24-hour liquid diet, deferral, or point-of-care ultrasound for higher-risk patients.)